Global Wearable Injectors Market was valued US$ 945.91 Mn in 2019 and is expected to reach US$ XX Mn by 2026, at a CAGR of XX % during a forecast period.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
To know about the Research Methodology:-Request Free Sample Report
The growing popularity of targeted therapies, favorable reimbursement, and technological advancements in wearable injectors are expected to drive the growth of the wearable injectors market. Additionally, an increase in the incidence of cancer and diabetes, and the adoption of advanced technological products are boosting the growth of the global wearable injectors market. Moreover, the increase in a number of injuries and technological advancements are expected to propel the growth of the global wearable injectors market.
The preference for alternative routes of drug delivery such as pens & auto-injectors are expected to restrain the growth of wearable injectors market. Additionally, increased healthcare cost and lack of awareness about advanced medical facilities limit the growth of the wearable injectors market.
The wearable injectors market is segmented into type, technology, application, end user, usage, and region.
Further, wearable injectors market based on type includes body-worn patch injector, off-body worn belt injector, and others. Wearable injectors market in terms of technology is segmented into the spring-based, motor-driven, rotary pump, expanding battery, and other. Based on the wearable injectors market, application segment is segmented into oncology, infectious disease, cardiovascular disease, autoimmune disease, and other. In terms of end-user segment wearable injectors market is segmented into hospital, clinic, home care, and other. Further, wearable injectors market based on usage includes disposable and semi-reusable. Based on regions, the global wearable injectors market is segmented into North America, Europe, Asia-pacific, Latin America and Middle East & Africa.
Based on the type, the body-worn patch injector segment is expected to dominate the market owing to increased demand, as these patches are comfortable to wear on the skin as well as they are also water resistant and convenient to use at home. The off body-worn injectors are applied to the body with the help of belts while the body worn patch injectors come with a glue which sticks to the body.
In terms of technology, the motor-driven segment is expected to register comparatively XX% CAGR over the forecast period, due to increasing customer demand for these devices as they are more convenient for use, as compared to others.
Among the regions, The Asia Pacific region is estimated to be the fastest growing region as compared to other region owing to the rising geriatric population coupled with incidences of chronic diseases and increasing awareness about the medical device such as wearable injector. The countries such as China and India are boosting the wearable injectors market in the Asia Pacific region over the forecast period.
The key player operating in global wearable injectors market are Amgen, Becton, Dickinson, and Company, Enable Injections, Insulet Corporation, Medtronic PLC, Sensile Medical, Steadymed Therapeutics, Tandem Diabetes Care, Inc., United Therapeutics Corporation, Valeritas, Inc., and Ypsomed.
The objective of the report is to present a comprehensive analysis of the Global Wearable Injectors Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors in the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Wearable Injectors Market dynamics, structure by analyzing the market segments and project the Global Wearable Injectors Market size. Clear representation of competitive analysis of key players by End-User Industry, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Wearable Injectors Market make the report investor’s guide.
Scope of Global Wearable Injectors Market: Inquire before buying
Global Wearable Injectors Market, by Type:
• Body-Worn Patch Injector
• Off-Body Worn Belt Injector
• Others
Global Wearable Injectors Market, by Technology:
• Spring-based
• Motor-driven
• Rotary Pump
• Expanding Battery
• Other
Global Wearable Injectors Market, by Application:
• Oncology
• Infectious Disease
• Cardiovascular Disease
• Autoimmune Disease
• Other
Global Wearable Injectors Market by End User:
• Hospital
• Clinic
• Home Care
• Other
Global Wearable Injectors Market by Usage:
• Disposable
• Semi-Reusable
Global Wearable Injectors Market, by Region:
• North America
• Europe
• Middle East & Africa
• Asia Pacific
• Latin America
Key players operating in Global Wearable Injectors Market:
• Amgen
• Becton, Dickinson and Company
• Enable Injections
• Insulet Corporation
• Medtronic PLC
• Sensile Medical (A Part of Gerresheimer)
• Steadymed Therapeutics
• Tandem Diabetes Care, Inc.
• United Therapeutics Corporation
• Valeritas, Inc.
• Ypsomed
• Therapeutics
• Sensile Medicals
• Bespak
• West Pharmaceutical Services, Inc.
• Dexcom, Inc.
• Cequr SA
• Debiotech S.A
• E3D Elcam Drug Delivery Devices
• Zealand Pharma A/S
